Rapid, low-cost fluorescent assay of β-lactamase-derived antibiotic resistance and related antibiotic susceptibility
暂无分享,去创建一个
Tayyaba Hasan | Akilan Palanisami | S Sibel Erdem | Shazia Khan | T. Hasan | Shazia Khan | A. Palanisami | S. Erdem
[1] Derek F. J. Brown,et al. Evaluation of the E test, a novel method of quantifying antimicrobial activity. , 1991, The Journal of antimicrobial chemotherapy.
[2] Giulio Jori,et al. Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications , 2006, Lasers in surgery and medicine.
[3] M. Kostrzewa,et al. Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Functional Assay for Rapid Detection of Resistance against β-Lactam Antibiotics , 2011, Journal of Clinical Microbiology.
[4] M. Aidoo. Divining without seeds: The case for strengthening laboratory medicine in Africa , 2011 .
[5] V. Gill,et al. Correlation of penicillin minimum inhibitory concentrations and penicillin zone edge appearance with staphylococcal beta-lactamase production , 1981, Journal of clinical microbiology.
[6] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[7] N. Woodford. Rapid characterization of beta-lactamases by multiplex PCR. , 2010, Methods in molecular biology.
[8] J. Sherris,et al. Antibiotic sensitivity testing. Report of an international collaborative study. , 1971, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.
[9] G. Jacoby,et al. Mechanisms of disease: The new β-lactamases , 2005 .
[10] I. Okeke. Divining without Seeds: The Case for Strengthening Laboratory Medicine in Africa , 2011 .
[11] Clsi. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .
[12] REPORT OF AN INTERNATIONAL COLLABORATIVE STUDY TO EVALUATE A WHO HIV-1 RNA GENOTYPE REFERENCE PANEL , 2003 .
[13] D. Livermore. beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.
[14] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[15] Andreas Wieser,et al. MALDI-TOF MS in microbiological diagnostics—identification of microorganisms and beyond (mini review) , 2011, Applied Microbiology and Biotechnology.
[16] Victor L. Yu,et al. Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory , 2001, Journal of Clinical Microbiology.
[17] R. Cantón,et al. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] A. Bauer,et al. Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.
[19] H. Goossens,et al. Antibiotic resistance—the need for global solutions , 2013, BDJ.
[20] Clinical,et al. Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .
[21] V. Lorian. Antibiotics in laboratory medicine , 2005 .
[22] G. Papanicolaou,et al. Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay , 1990, Antimicrobial Agents and Chemotherapy.
[23] A. L. Koch. Penicillin Binding Proteins, β-Lactams, and Lactamases: Offensives, Attacks, and Defensive Countermeasures , 2000, Critical reviews in microbiology.
[24] Suzanne Fery-Forgues,et al. ARE FLUORESCENCE QUANTUM YIELDS SO TRICKY TO MEASURE? A DEMONSTRATION USING FAMILIAR STATIONERY PRODUCTS , 1999 .
[25] Ulysses W. Sallum,et al. Rapid Functional Definition of Extended Spectrum β‐Lactamase Activity in Bacterial Cultures via Competitive Inhibition of Fluorescent Substrate Cleavage , 2010, Photochemistry and photobiology.
[26] D. Livermore,et al. Detection of beta-lactamase-mediated resistance. , 2001, The Journal of antimicrobial chemotherapy.
[27] K. Thomson,et al. Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests , 1992, Antimicrobial Agents and Chemotherapy.
[28] Ulysses W. Sallum,et al. Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA. , 2009, Angewandte Chemie.
[29] T. Hasan,et al. Functional Targeting of Bacteria: A Multimodal Construct for PDT and Diagnostics of Drug-Resistant Bacteria , 2014 .
[30] T. F. Smith,et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing , 2006, Clinical Microbiology Reviews.
[31] P. Nordmann,et al. Emerging carbapenemases in Gram-negative aerobes. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[32] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[33] G. Jacoby,et al. The new beta-lactamases. , 2005, The New England journal of medicine.
[34] Ulysses W. Sallum,et al. Rapid optical determination of β-lactamase and antibiotic activity , 2014, BMC Microbiology.
[35] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[36] D. Livermore,et al. Detection of β-lactamase-mediated resistance , 2001 .
[37] J. Rodríguez-Baño,et al. Clinical significance of extended-spectrum β-lactamases , 2008, Expert review of anti-infective therapy.